LOS ANGELES--(BUSINESS WIRE)--Universal Detection Technology (www.udetection.com) (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, announced today that it will become a featured exporter of biological weapon detection equipment in South Korea. The U.S. Department of Commerce's Commercial Service will assist UNDT in the listing. According to a South Korean defense ministry report issued yesterday, the North Korean regime is capable of unleashing 13 types of lethal biological agents.
In one of the most detailed assessments of the dictatorship’s biological weapons arsenal, the report said that North Korea has the ability to launch as many as 13 kinds of viral and bacterial attacks. In a submission to the South Korean National Assembly, the defense minister also said that the North has 5,000 tons of chemical weapons, believed to include mustard gas, phosgene and sarin. Among its biological agents are anthrax, cholera, yellow fever, smallpox, typhus, typhoid fever and dysentery.
Universal Detection Technology’s 5-agent Bioterrorism detection kits, the premier product available under the agreement, have been extensively used by first responders and private industry throughout the United States. Testing of the kits by the U.S. DOD as well as the United Kingdom military show that the kits demonstrate no cross-reactivity with near neighbor species and no false positives with commonly encountered "white powders." The kits are designed to test for anthrax, botulinum toxin, Ricin, plague (Y. Pestis) and SEB's in as little as three minutes.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, Universal Detection Technology, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems and antimicrobial products. www.udetection.com.
Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.